Pathogenesis of vascular complications in Cushing's syndrome

Predrag Miljic1, Dragana Miljic, Joshua William Cain

  • 1Clinic for Hematology, University Clinical Center, Faculty of Medicine, Belgrade University, Belgrade, Serbia.

Hormones (Athens, Greece)
|March 28, 2012
PubMed

Insights

Cushing's syndrome (CS) increases thrombosis risk due to hormonal imbalances affecting blood clotting. Further research is needed to prevent cardiovascular events in CS patients.

Area of Science:

  • Endocrinology
  • Hematology
  • Cardiovascular Medicine

Background:

  • Chronic high glucocorticoid levels in Cushing's syndrome (CS) are linked to hemostatic system alterations.
  • CS patients exhibit increased atherothrombotic and venous thromboembolic events (VTE), leading to a five-fold higher mortality rate from cardiovascular complications.
  • The precise mechanisms driving the prothrombotic state in CS remain incompletely understood.

Purpose of the Study:

  • To investigate the prothrombotic state in Cushing's syndrome.
  • To elucidate the underlying mechanisms contributing to hypercoagulability and thrombophilic phenotypes in CS.
  • To identify potential strategies for preventing cardiovascular complications in CS patients.

Main Methods:

  • Review of existing literature on hemostatic abnormalities in CS.
  • Analysis of documented changes in coagulation factors (e.g., Factor VIII, von Willebrand factor).
  • Consideration of the Virchow triad components (endothelial dysfunction, hypercoagulability, stasis) in CS pathogenesis.

Main Results:

  • Elevated levels of Factor VIII and von Willebrand factor are frequently observed.
  • Evidence suggests enhanced thrombin generation and reduced fibrinolytic activity.
  • The contribution of these specific hemostatic changes to the overall prothrombotic phenotype requires further clarification.

Conclusions:

  • Cushing's syndrome is associated with multiple hemostatic abnormalities contributing to a prothrombotic state.
  • Endothelial dysfunction, hypercoagulability, and stasis likely play variable roles in CS-related thrombosis.
  • Larger studies are necessary to develop effective prevention strategies for cardiovascular complications in CS.

Related Concept Videos

Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
Adrenal Gland Disorders01:27

Adrenal Gland Disorders

Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Cytotoxic Edema: Pathophysiology01:21

Cytotoxic Edema: Pathophysiology

Cytotoxic edema is a form of cerebral edema characterized by intracellular swelling of neurons, astrocytes, and other glial cells. It develops when the mechanisms responsible for maintaining ionic gradients across the cell membrane become impaired. Under normal physiological conditions, the sodium–potassium ATPase actively transports sodium ions out of the cell and potassium ions into the cell, preserving osmotic balance and enabling electrical signaling. This pump requires a continuous supply...
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...